Clinical Trial Update: A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa [Phase 2]

View source ↗

Summary

This document provides an update on a completed Phase 2b trial of istradefylline (KW-6002) as add-on therapy to levodopa for Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• istradefylline (istradefylline)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED